2010
//
Network Medicine

Blueprint for antimicrobial hit discovery targeting metabolic networks

Abstract
Proceedings of the National Academy of Sciences of the United States of America 10.1073, 1-6 (2010) Advances in genome analysis, network biology, and computational chemistry have the potential to revolutionize drug discovery by combining system-level identification of drug targets with the atomistic modeling of small molecules capable of modulating their activity. To demonstrate the effectiveness of such a discovery pipeline, we deduced common antibiotic targets in Escherichia coli and Staphylococcus aureus by identifying shared tissue-specific or uniformly essential metabolic reactions in their metabolic networks. We then predicted through virtual screening dozens of potential inhibitors for several enzymes of these reactions and showed experimentally that a subset of these inhibited both enzyme activities in vitro and bacterial cell viability. This blueprint is applicable for any sequenced organism with high-quality metabolic reconstruction and suggests a general strategy for strain-specific antiinfective therapy.

..

More publications
A.-L. Barabási

Science 325, 412-413 (2009)

view
J.-P. Onnela, J. Saramäki, J. Hyvönen, G. Szabó, M A. de Menezes, K. Kaski, A.-L. Barabási, J. Kertész

New Journal of Physics 9, 1-27 (2007)

view
V. Vermeirssen, M. Inmaculada Barrasa, C. Hidalgo, J.-A. B. Babon, R. Sequerra, L. Doucette-Stamm, A.-L. Barabási, A. J.M. Walhout

Genome Research 17, 061-1071 (2007)

view